Skip to main content
. Author manuscript; available in PMC: 2013 Oct 29.
Published in final edited form as: Hepatology. 2013 Aug 6;58(4):10.1002/hep.26484. doi: 10.1002/hep.26484

Fig. 8.

Fig. 8

Schematic diagram illustrating the role of Hh and PLK2 signaling in promoting CCA cell resistance to endogenous TRAIL cytotoxicity. Hh or PLK inhibitors, such as cyclopamine or BI 6727, block Hh/ PLK2 survival signaling and thus promote apoptosis in CCA cells.